Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia - Teva…

<a href="https://news.google.com/rss/articles/CBMiywNBVV95cUxQV1NMcTdkbFZwcVpKRW…; target="_blank">Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia</a>&nbsp;&nbsp;<font color="#6f6f6f">Teva Pharmaceuticals</font>